Isabelle Houde

1.3k total citations
40 papers, 1.0k citations indexed

About

Isabelle Houde is a scholar working on Transplantation, Surgery and Oncology. According to data from OpenAlex, Isabelle Houde has authored 40 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Transplantation, 16 papers in Surgery and 10 papers in Oncology. Recurrent topics in Isabelle Houde's work include Renal Transplantation Outcomes and Treatments (22 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Cytomegalovirus and herpesvirus research (8 papers). Isabelle Houde is often cited by papers focused on Renal Transplantation Outcomes and Treatments (22 papers), Organ Transplantation Techniques and Outcomes (12 papers) and Cytomegalovirus and herpesvirus research (8 papers). Isabelle Houde collaborates with scholars based in Canada, United States and France. Isabelle Houde's co-authors include François Davodeau, Marc Bonneville, Henri Vié, Marie‐Alix Peyrat, Marie Alix Peyrat, Isabelle Côté, Sacha A. De Serres, Raynald Roy, Marthe Belles‐Isles and M M Hallet and has published in prestigious journals such as Science, Journal of Biological Chemistry and The Journal of Immunology.

In The Last Decade

Isabelle Houde

39 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Isabelle Houde Canada 20 388 385 255 177 167 40 1.0k
Nina Tolkoff‐Rubin United States 18 287 0.7× 613 1.6× 432 1.7× 180 1.0× 220 1.3× 29 1.2k
Medhat Askar United States 21 495 1.3× 627 1.6× 484 1.9× 106 0.6× 163 1.0× 93 1.3k
Dechu Puliyanda United States 18 290 0.7× 609 1.6× 333 1.3× 145 0.8× 255 1.5× 43 1.1k
G. Russo United States 9 359 0.9× 993 2.6× 455 1.8× 184 1.0× 336 2.0× 18 1.4k
Marije C. Baas Netherlands 16 205 0.5× 276 0.7× 229 0.9× 116 0.7× 79 0.5× 38 677
Patrizia Amico Switzerland 16 242 0.6× 877 2.3× 516 2.0× 152 0.9× 196 1.2× 38 1.1k
W. Harmon United States 16 130 0.3× 403 1.0× 260 1.0× 201 1.1× 74 0.4× 33 803
David San Segundo Spain 18 661 1.7× 761 2.0× 440 1.7× 90 0.5× 289 1.7× 100 1.5k
G. Mogilishetty United States 15 340 0.9× 918 2.4× 511 2.0× 254 1.4× 125 0.7× 30 1.3k
Enrico Minetti Italy 14 327 0.8× 281 0.7× 210 0.8× 150 0.8× 75 0.4× 35 851

Countries citing papers authored by Isabelle Houde

Since Specialization
Citations

This map shows the geographic impact of Isabelle Houde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Isabelle Houde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Isabelle Houde more than expected).

Fields of papers citing papers by Isabelle Houde

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Isabelle Houde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Isabelle Houde. The network helps show where Isabelle Houde may publish in the future.

Co-authorship network of co-authors of Isabelle Houde

This figure shows the co-authorship network connecting the top 25 collaborators of Isabelle Houde. A scholar is included among the top collaborators of Isabelle Houde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Isabelle Houde. Isabelle Houde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Côté, Isabelle, Julie Lesage, Isabelle Houde, et al.. (2024). HLA class, calcineurin inhibitor levels, and the risk of graft failure in kidney recipients with de novo donor-specific antibodies. Frontiers in Immunology. 15. 1493878–1493878. 1 indexed citations
2.
3.
Cockfield, Sandra M., Patricia Campbell, Marcelo Cantarovich, et al.. (2018). Comparison of the effects of standard vs low-dose prolonged-release tacrolimus with or without ACEi/ARB on the histology and function of renal allografts. American Journal of Transplantation. 19(6). 1730–1744. 26 indexed citations
4.
Cardinal, Héloïse, A. Lagacé, Martin Albert, et al.. (2018). Organ donor management and delayed graft function in kidney transplant recipients: A multicenter retrospective cohort study. American Journal of Transplantation. 19(1). 277–284. 27 indexed citations
5.
Richardson, Robert, Maureen T. Connelly, Christine Dipchand, et al.. (2015). Kidney Paired Donation Protocol for Participating Donors 2014. Transplantation. 99(Supplement 10). S1–S88. 36 indexed citations
6.
Lesage, Julie, Isabelle Côté, Éric Wagner, et al.. (2014). Donor-Specific Antibodies, C4d and Their Relationship With the Prognosis of Transplant Glomerulopathy. Transplantation. 99(1). 69–76. 37 indexed citations
7.
Serres, Sacha A. De, Yves Caumartin, Jean-Guy Lachance, et al.. (2010). Dual-Kidney Transplants as an Alternative for Very Marginal Donors: Long-Term Follow-Up in 63 Patients. Transplantation. 90(10). 1125–1130. 27 indexed citations
8.
Serres, Sacha A. De, Karine Marquis, Richard Larivière, et al.. (2010). Age-related and blood pressure-independent reduction in aortic stiffness after kidney transplantation. Journal of Hypertension. 29(1). 130–136. 33 indexed citations
9.
Noiseux, Nicolas, Juliette Dupont, Isabelle Houde, et al.. (2009). Pulmonary Recruitment Protocol For Organ Donors: A New Strategy to Improve the Rate of Lung Utilization. Transplantation Proceedings. 41(8). 3284–3289. 19 indexed citations
10.
Boudreault, Alexandre A., Chantal Courtemanche, Éva Latulippe, et al.. (2009). Screening for polyomavirus associated nephropathy in renal transplantation with blood viral load measurement. Journal of Clinical Virology. 45(4). 318–321. 17 indexed citations
11.
Cardinal, Héloïse, Marie‐Josée Hébert, Elham Rahme, et al.. (2005). Modifiable factors predicting patient survival in elderly kidney transplant recipients. Kidney International. 68(1). 345–351. 45 indexed citations
12.
Radeau, T., Marcel Lebel, Isabelle Houde, et al.. (2004). Endothelin-1 levels and cardiovascular risk factors in renal transplant patients. Clinical Biochemistry. 37(12). 1072–1078. 3 indexed citations
13.
Lemieux, Isabelle, Isabelle Houde, Agnès Pascot, et al.. (2002). Effects of prednisone withdrawal on the new metabolic triad in cyclosporine-treated kidney transplant patients. Kidney International. 62(5). 1839–1847. 37 indexed citations
14.
Houde, Isabelle, et al.. (2000). MYCOPHENOLATE MOFETIL, AN ALTERNATIVE TO CYCLOSPORINE A FOR LONG-TERM IMMUNOSUPPRESSION IN KIDNEY TRANSPLANTATION?1,2. Transplantation. 70(8). 1251–1253. 31 indexed citations
15.
Radeau, T., Marie‐Claude Vohl, Isabelle Houde, et al.. (2000). HDL Cholesterol and TaqIB Cholesteryl Ester Transfer Protein Gene Polymorphism in Renal Transplant Recipients. ˜The œNephron journals/Nephron journals. 84(4). 333–341. 8 indexed citations
16.
Belles‐Isles, Marthe, et al.. (1998). MONITORING OF CYTOMEGALOVIRUS INFECTIONS BY THE CD8+CD38+ T-CELL SUBSET IN KIDNEY TRANSPLANT RECIPIENTS. Transplantation. 65(2). 279–282. 29 indexed citations
17.
Romagné, François, Marie Alix Peyrat, Carlo Leget, et al.. (1996). Structural analysis of γδ TCR using a novel set of TCR γ and δ chain-specific monoclonal antibodies generated against soluble γδ TCR. Journal of Immunological Methods. 189(1). 25–36. 9 indexed citations
18.
19.
Davodeau, François, Isabelle Houde, G. Boulot, et al.. (1993). Secretion of disulfide-linked human T-cell receptor gamma delta heterodimers. Journal of Biological Chemistry. 268(21). 15455–15460. 23 indexed citations
20.
Davodeau, François, Marie‐Alix Peyrat, M M Hallet, et al.. (1993). Close correlation between Daudi and mycobacterial antigen recognition by human gamma delta T cells and expression of V9JPC1 gamma/V2DJC delta-encoded T cell receptors.. The Journal of Immunology. 151(3). 1214–1223. 117 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nina Tolkoff‐Rubin Breakdown of academic impact, for papers by Medhat Askar Breakdown of academic impact, for papers by Dechu Puliyanda Breakdown of academic impact, for papers by G. Russo Breakdown of academic impact, for papers by Marije C. Baas Breakdown of academic impact, for papers by Patrizia Amico Breakdown of academic impact, for papers by W. Harmon Breakdown of academic impact, for papers by David San Segundo Breakdown of academic impact, for papers by G. Mogilishetty Breakdown of academic impact, for papers by Enrico Minetti
Rankless by CCL
2026